跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-HYDROXYUREA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-HYDROXYUREA
Authorized
STANDARD
RIVA-HYDROXYUREA
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5e50aeb7d11e1b11
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
5e50aeb7d11e1b11
Drug Approval Canada Name
RIVA-HYDROXYUREA
Product Name
RIVA-HYDROXYUREA
Status
Marketed
Status Date
2023-05-01
Original Market Date
2023-05-01
Din
02530260
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XX05 HYDROXYCARBAMIDE
Atc Name
l 01 xx 05
Aig Number
0113432001
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
HYDROXYUREA
500 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5e50aeb7d11e1b11
Type
Standard
Back to Health Canada Approvals